Tag Archives: Pfizer Inc.

Initiating Coverage of Pfizer (PFE)

Buy Rating. Price Target of $30. As the COVID-19 pandemic receded, Pfizer’s sales and profits fell sharply.  Combined sales and alliance revenues of COMIRNATY, the COVID vaccine, and PAXLOVID, the COVID oral antiviral, fell 78% to $12.5 billion in 2023.  … Continue reading

Posted in Health Care, PFE | Tagged , | Comments Off on Initiating Coverage of Pfizer (PFE)